Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Quiz Plus CT Reveal Heart Attack Risk

By HospiMedica staff writers
Posted on 20 Sep 2002
German scientists have developed a simple point-scoring quiz for determining a patient's risk of heart attack. More...
When combined with computed tomography (CT), the results are even more accurate.

The point-scoring system, called the Prospective Cardiovascular Muenster (PROCLAM) calculator, was developed by Gerd Assmann, M.D., of the University of Muenster (Germany). Dr. Assmann and colleagues studied more than 30,000 men and women in the Ruhr valley region. Of the 60 factors measured in all participants, eight turned out to be necessary to accurately predict heart attack risk. These factors are low-density lipoprotein level (LDL), high-density lipoprotein level (HDL), fasting triglyceride level, systolic blood pressure, smoking, diabetes, and having a first-degree relative who had a heart attack before the age of 60.

When men in the top fifth of the scoring had a CT scan with the Somatom Sensation 16 from Siemens Medical Solutions (Erlangen, Germany), no fewer than 82% had lesions in their blood vessels indicative of coronary artery disease, while men in the bottom fifth of the scoring were free of such lesions. These results were presented at the 6th International Symposium on Global Risk of Coronary Heart Disease and Stroke, held in Florence, Italy.

"CT scanning for quantification of hard and soft coronary lesions in individuals at risk, as determined by the PROCAM score, is a valuable and noninvasive means of finding those patients who urgently require medical or even surgical treatment to prevent an imminent heart attack,” said Dr. Assmann. "Combining this score with Siemens' CT technology creates a powerful tool for identifying high-risk patients before heart attacks occur,” he added.




Related Links:
Siemens Medical Solutions
University of Muenster

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.